Hap Trading, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $2.76 Million - $3.35 Million	35,000 New	35,000 $91 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $111,832 - $223,216	-2,800 Reduced 16.37%	14,300 $293,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $50,484 - $97,789	1,400 Added 8.92%	17,100 $85,000
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $45,654 - $98,175	2,100 Added 15.44%	15,700 $107,000
Q1 2022 May 12, 2022	SELL	$23.7 - $41.39 $300,990 - $525,653	-12,700 Reduced 48.29%	13,600 $127,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $365,330 - $515,984	11,900 Added 82.64%	26,300 $124,000
Q3 2021 Nov 10, 2021	BUY	$19.91 - $68.26 $51,766 - $177,476	2,600 Added 22.03%	14,400 $94,000
Q2 2021 Aug 11, 2021	BUY	$50.63 - $73.5 $597,434 - $867,300	11,800 New	11,800 $62,000
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $972,833 - $1.42 Million	-17,400 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $908,447 - $1.19 Million	-13,700 Reduced 44.05%	17,400 $97,000
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $5.55 Million - $6.97 Million	-81,200 Reduced 72.31%	31,100 $19,000
Q2 2020 Aug 10, 2020	SELL	$49.87 - $98.69 $2.47 Million - $4.89 Million	-49,500 Reduced 30.59%	112,300 $1.25 Million
Q1 2020 May 08, 2020	SELL	$41.2 - $101.31 $490,280 - $1.21 Million	-11,900 Reduced 6.85%	161,800 $139,000
Q4 2019 Feb 11, 2020	BUY	$16.71 - $106.24 $2.68 Million - $17.1 Million	160,600 Added 1225.95%	173,700 $12 Million
Q3 2019 Nov 12, 2019	BUY	$20.24 - $29.16 $265,144 - $381,996	13,100 New	13,100 $46,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.